Literature DB >> 17507462

Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut.

David P Wilson1, Joseph J Mattapallil, Matthew D H Lay, Lei Zhang, Mario Roederer, Miles P Davenport.   

Abstract

CD4+ T-cell depletion during acute human immunodeficiency virus infection occurs predominantly in the gastrointestinal mucosa. Using experimental data on SIV(mac251) viral load in blood and CD4+ T cells in the jejunum, we modeled the kinetics of CD4+ T-cell infection and death and estimated the viral infectivity. The infectivity of SIV(mac251) is higher than previously estimated for SHIV89.6P infection, but this higher infectivity is offset by a lower average peak viral load in SIV(mac251). Thus, the dynamics of target cell infection and death are remarkably similar between a CXCR4- and a CCR5-tropic infection in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507462      PMCID: PMC1951284          DOI: 10.1128/JVI.01771-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians.

Authors:  J Carpenter; J Bithell
Journal:  Stat Med       Date:  2000-05-15       Impact factor: 2.373

2.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

Authors:  D H Barouch; S Santra; J E Schmitz; M J Kuroda; T M Fu; W Wagner; M Bilska; A Craiu; X X Zheng; G R Krivulka; K Beaudry; M A Lifton; C E Nickerson; W L Trigona; K Punt; D C Freed; L Guan; S Dubey; D Casimiro; A Simon; M E Davies; M Chastain; T B Strom; R S Gelman; D C Montefiori; M G Lewis; E A Emini; J W Shiver; N L Letvin
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

3.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 4.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  Rama Rao Amara; Francois Villinger; John D Altman; Shari L Lydy; Shawn P O'Neil; Silvija I Staprans; David C Montefiori; Yan Xu; James G Herndon; Linda S Wyatt; Maria Angelito Candido; Natalia L Kozyr; Patricia L Earl; James M Smith; Hak-Ling Ma; Bennett D Grimm; Michael L Hulsey; Harold M McClure; Janet M McNicholl; Bernard Moss; Harriet L Robinson
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

5.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Authors:  J R Mascola; G Stiegler; T C VanCott; H Katinger; C B Carpenter; C E Hanson; H Beary; D Hayes; S S Frankel; D L Birx; M G Lewis
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

6.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.

Authors:  J D Lifson; J L Rossio; R Arnaout; L Li; T L Parks; D K Schneider; R F Kiser; V J Coalter; G Walsh; R J Imming; B Fisher; B M Flynn; N Bischofberger; M Piatak; V M Hirsch; M A Nowak; D Wodarz
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

9.  Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics.

Authors:  R A Parker; M M Regan; K A Reimann
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Amir Horowitz; Arlene Hurley; Christine Hogan; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  8 in total

1.  CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo.

Authors:  Janka Petravic; Liyen Loh; Stephen J Kent; Miles P Davenport
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

2.  Is the gut the major source of virus in early simian immunodeficiency virus infection?

Authors:  Matthew D H Lay; Janka Petravic; Shari N Gordon; Jessica Engram; Guido Silvestri; Miles P Davenport
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

3.  Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections.

Authors:  Janka Petravic; Ruy M Ribeiro; Danilo R Casimiro; Joseph J Mattapallil; Mario Roederer; John W Shiver; Miles P Davenport
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

Review 4.  Gut Microbiome Homeostasis and the CD4 T- Follicular Helper Cell IgA Axis in Human Immunodeficiency Virus Infection.

Authors:  Olusegun O Onabajo; Joseph J Mattapallil
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

5.  Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection.

Authors:  Liyen Loh; Jeanette C Reece; Caroline S Fernandez; Sheilajen Alcantara; Robert Center; Jane Howard; Damian F J Purcell; Mehala Balamurali; Janka Petravic; Miles P Davenport; Stephen J Kent
Journal:  PLoS Pathog       Date:  2009-04-10       Impact factor: 6.823

6.  Improving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model.

Authors:  Hiroki Ikeda; Rob J de Boer; Kei Sato; Satoru Morita; Naoko Misawa; Yoshio Koyanagi; Kazuyuki Aihara; Shingo Iwami
Journal:  Theor Biol Med Model       Date:  2014-05-21       Impact factor: 2.432

7.  Gender differences in innate responses and gene expression profiles in memory CD4 T cells are apparent very early during acute simian immunodeficiency virus infection.

Authors:  Jeffy George; Ryan C Johnson; Mary J Mattapallil; Lynnsey Renn; Ronald Rabin; D Scott Merrell; Joseph J Mattapallil
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

8.  Microbial Dysbiosis During Simian Immunodeficiency Virus Infection is Partially Reverted with Combination Anti-retroviral Therapy.

Authors:  Faith C Blum; Britney L Hardy; Kimberly A Bishop-Lilly; Kenneth G Frey; Theron Hamilton; James B Whitney; Mark G Lewis; D Scott Merrell; Joseph J Mattapallil
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.